Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Two Shionogi patents describe novel immunosuppressant agents

Oct. 2, 2002

Novel immunosuppressants in early development at Sumitomo

Oct. 1, 2002

Positive phase I results for AGI-1096 in prevention of transplant rejection

Oct. 1, 2002

TNX-901 for peanut allergy receives fast track status

Sep. 26, 2002

Tracvax protects against Chlamydia infection in preclinical studies

Sep. 26, 2002

Fujisawa and Pharmagenesis collaborate on triptolide derivatives

Sep. 25, 2002

Beneficial effects on chronic lung rejection reported for switching from ciclosporin to tacrolimus

Sep. 23, 2002

VX-148: a novel IMP dehydrogenase inhibitor with a favorable preclinical profile

Sep. 20, 2002

EMEA grants orphan drug status to APT-070 in kidney transplantation

Sep. 19, 2002

Therion licenses rights to ICAM-1 from Boehringer Ingelheim

Sep. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...